Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Trending Today

U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. The tech-heavy index closed at 13,917.89 for the day.

The Dow Jones Industrial Average also reflected an upward trend, increasing by 0.25% to reach 34,663.72. Similarly, the S&P 500 index followed suit, marking a 0.67% rise to settle at 4,487.46.

These are the top stocks that gained the attention of retail traders and investors throughout the day:

Oracle Corporation ORCL
Oracle’s stock performance for the day saw a slight increase of 0.31%, closing at $126.71. The stock reached an intraday high of $127.42 and a low of $124.72. Its 52-week range spans from $60.78 to $127.54. Oracle reported a first-quarter revenue of $12.45 billion, marking a 9% year-over-year growth. The company’s cloud revenue, which totaled $4.6 billion, saw a significant 30% increase from the previous year. Larry Ellison, Oracle’s Chairman and CTO, emphasized the potential of Generative AI, hinting at its transformative capabilities.

Tesla, Inc. TSLA
Tesla’s stock surged by a remarkable 10.09%, closing at $273.58. The stock peaked at an intraday high of $274.85 and dipped to a low of $260.61. Its 52-week range is between $101.81 and $313.8. Morgan Stanley analyst Adam Jonas recently highlighted Tesla’s custom supercomputer, Dojo, as a potential game-changer, predicting it could significantly boost the Elon Musk-led company’s enterprise value.

Novavax, Inc. NVAX
Novavax experienced a decline of 12.88%, with its stock closing at $7.82. The stock’s intraday high and low were $9.02 and $7.73, respectively, and its 52-week range is between $5.61 and $33.37. While Moderna and Pfizer received FDA approval for their updated COVID-19 vaccines, Novavax, which uses protein-based technology, is still awaiting a nod from the FDA.

DraftKings Inc. DKNG
DraftKings’ stock saw a minor dip of 0.19%, closing at $31.79. The stock’s intraday high was $32.65, and its low was $31.52. Over the past 52 weeks, the stock has ranged from $10.69 to $34.49. DraftKings recently faced criticism for a “Never Forget” parlay promotion, which they later apologized for, emphasizing their respect for the significance of 9/11.

Pfizer Inc. PFE
Pfizer’s stock declined by 0.91%, closing at $33.94. The stock’s intraday high and low were $34.3 and $33.54, respectively, with a 52-week range between $33.54 and $54.93. Recent data indicates that Pfizer’s short percent of float has risen, suggesting a shift in market sentiment towards the stock.

Photo by Phongphan on Shutterstock

Prepare for the day's trading with top premarket movers and news by Benzinga.

Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal

The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.

Market News and Data brought to you by Benzinga APIs
Posted In: EquitiesNewsMarketsMediaDraftKingselectric vehiclesElon MuskEVsNovavaxOraclePfizer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!